首页 > 最新文献

Biochemia Medica最新文献

英文 中文
Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol. 载脂蛋白B浓度与Friedewald、Martin-Hopkins和Sampson计算LDL胆固醇公式的一致性。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2022-02-15 Epub Date: 2021-12-15 DOI: 10.11613/BM.2022.010704
Pieter-Jan Briers, Michel R Langlois

Introduction: Two new formulas, the Martin-Hopkins and the Sampson formula, were recently developed to overcome shortcomings of the Friedewald formula for calculating LDL-cholesterol. We aimed to compare the concordance of the two formulas with apolipoprotein B (apoB), a surrogate marker of the number of LDL particles.

Materials and methods: In a study of serum lipid data of 1179 patients who consulted the AZ St-Jan Hospital Bruges for cardiovascular risk assessment, the correlation and concordance of the Friedewald, Martin-Hopkins and Sampson formulas with apoB concentration, measured by immunonephelometry, were determined and compared.

Results: The Martin-Hopkins formula showed significantly higher correlation coefficient than the Friedewald formula with apoB in the entire dataset and in patients with low LDL-cholesterol < 1.8 mmol/L. Both Martin-Hopkins and Sampson formulas yielded > 70% concordance of LDL-cholesterol with regard to treatment group classification based on population-equivalent thresholds of apoB in hypertriglyceridemic patients (2-4.5 mmol/L), with the highest concordance (75.6%) obtained using Martin-Hopkins formula vs. 60.5% with Friedewald formula.

Conclusion: The Martin-Hopkins (and, to a lesser extent, Sampson) formula is more closely associated with the number of LDL particles than Friedewald formula. This, in combination with literature evidence of lesser accuracy of the Friedewald formula, is an argument to switch from Friedewald to a modified, improved formula.

介绍:两个新的公式,马丁-霍普金斯和桑普森公式,最近发展克服了计算低密度脂蛋白胆固醇的弗里德瓦尔德公式的缺点。我们的目的是比较两种配方与载脂蛋白B (apoB)的一致性,载脂蛋白B是LDL颗粒数量的替代标记物。材料与方法:对1179例就诊于Bruges AZ St-Jan医院进行心血管风险评估的患者的血脂数据进行研究,确定并比较Friedewald、Martin-Hopkins和Sampson配方与免疫比浊法测定的载脂蛋白ob浓度的相关性和一致性。结果:在整个数据集和低ldl -胆固醇< 1.8 mmol/L的患者中,Martin-Hopkins公式与载脂蛋白ob的相关系数显著高于Friedewald公式。根据高甘油三酯血症患者(2-4.5 mmol/L)载脂蛋白ob的人群等效阈值进行治疗组分类时,Martin-Hopkins和Sampson公式的ldl -胆固醇一致性均> 70%,其中Martin-Hopkins公式的一致性最高(75.6%),而Friedewald公式的一致性最高(60.5%)。结论:与Friedewald公式相比,Martin-Hopkins公式(在较小程度上,Sampson公式)与LDL颗粒数量的关系更为密切。这一点,再加上弗里德瓦尔德公式准确性较低的文献证据,是一个从弗里德瓦尔德公式转向一个修改的、改进的公式的理由。
{"title":"Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol.","authors":"Pieter-Jan Briers,&nbsp;Michel R Langlois","doi":"10.11613/BM.2022.010704","DOIUrl":"https://doi.org/10.11613/BM.2022.010704","url":null,"abstract":"<p><strong>Introduction: </strong>Two new formulas, the Martin-Hopkins and the Sampson formula, were recently developed to overcome shortcomings of the Friedewald formula for calculating LDL-cholesterol. We aimed to compare the concordance of the two formulas with apolipoprotein B (apoB), a surrogate marker of the number of LDL particles.</p><p><strong>Materials and methods: </strong>In a study of serum lipid data of 1179 patients who consulted the AZ St-Jan Hospital Bruges for cardiovascular risk assessment, the correlation and concordance of the Friedewald, Martin-Hopkins and Sampson formulas with apoB concentration, measured by immunonephelometry, were determined and compared.</p><p><strong>Results: </strong>The Martin-Hopkins formula showed significantly higher correlation coefficient than the Friedewald formula with apoB in the entire dataset and in patients with low LDL-cholesterol < 1.8 mmol/L. Both Martin-Hopkins and Sampson formulas yielded > 70% concordance of LDL-cholesterol with regard to treatment group classification based on population-equivalent thresholds of apoB in hypertriglyceridemic patients (2-4.5 mmol/L), with the highest concordance (75.6%) obtained using Martin-Hopkins formula <i>vs</i>. 60.5% with Friedewald formula.</p><p><strong>Conclusion: </strong>The Martin-Hopkins (and, to a lesser extent, Sampson) formula is more closely associated with the number of LDL particles than Friedewald formula. This, in combination with literature evidence of lesser accuracy of the Friedewald formula, is an argument to switch from Friedewald to a modified, improved formula.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"32 1","pages":"010704"},"PeriodicalIF":3.3,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39851746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Corrigendum to: Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine. 抗核抗体评估的勘误:代表克罗地亚医学生物化学和实验室医学学会提出的国家建议。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2022-02-15 DOI: 10.11613/BM.2022.011201
Andrea Tešija Kuna, Lovorka Đerek, Vedrana Drvar, Ana Kozmar, Katarina Gugo

[This corrects the article DOI: 10.11613/BM.2021.020502.].

[更正文章DOI: 10.11613/BM.2021.020502.]。
{"title":"Corrigendum to: Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine.","authors":"Andrea Tešija Kuna,&nbsp;Lovorka Đerek,&nbsp;Vedrana Drvar,&nbsp;Ana Kozmar,&nbsp;Katarina Gugo","doi":"10.11613/BM.2022.011201","DOIUrl":"https://doi.org/10.11613/BM.2022.011201","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.11613/BM.2021.020502.].</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"32 1","pages":"011201"},"PeriodicalIF":3.3,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833248/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39670810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Verification of automatic analysers Roller 20PN and iSED for measuring erythrocyte sedimentation rate. 用于测量红细胞沉降率的自动分析仪Roller 20PN和ise的验证。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2022-02-15 DOI: 10.11613/BM.2022.010708
Helena Čičak, Pavica Šonjić, Ana-Maria Šimundić

Introduction: Automated erythrocyte sedimentation rate (ESR) analysers are based on different methodology than Westergren method. It is questionable whether ESR values obtained from those analysers are comparable with determined values with Westergren method. The aim was verification of the precision, method comparison and accuracy of automated ESR analysers: Roller 20PN (Alifax S.p.A., Polverara, Italy) and iSED (Alcor Scientific, Smithfield, USA).

Materials and methods: Blood samples (N = 752 for Roller 20PN and N = 213 for iSED) were sampled into K2EDTA (Kima, Italy) tubes for automated and 3.8% Na-citrate tubes (Kima, Italy) for Westergren method. The data was divided into three groups according to the ESR values obtained with the Westergren method: Group Low (L) (ESR ≤ 20 mm), Group Medium (M) (ESR 21-60 mm), and Group High (H) (ESR ≥ 61 mm). Method agreement was assessed by Bland-Altman analysis and Passing-Bablok regression.

Results: Analyser iSED has shown better comparability with Westergren method (bias 0.0 (95%Cl -1.4 to 1.5) range than Roller 20 PN (bias = - 6.4 (95%Cl - 7.1 to -5.7) in the whole measuring. For Roller 20 PN, Passing-Bablok regression has shown constant and proportional difference for Groups L and M, and for iSED only for Group H. Roller 20 PN had lower sensitivity (0.51 (95%Cl: 0.45-0.57) than iSED (0.72 (95%Cl: 0.59-0.80) while they had comparable specificity (> 0.90) and accuracy (≥ 0.80) in comparison with the Westergren method.

Conclusion: Both analysers are not comparable with the Westergren method and should not be used interchangeably.

简介:自动红细胞沉降率(ESR)分析仪是基于不同的方法比Westergren方法。从这些分析仪获得的ESR值是否与Westergren方法确定的值具有可比性是值得怀疑的。目的是验证自动ESR分析仪的精度、方法比较和准确性:Roller 20PN (Alifax S.p.A, Polverara,意大利)和iSED (Alcor Scientific, Smithfield,美国)。材料和方法:将血液样本(Roller 20PN取N = 752, iSED取N = 213)送入K2EDTA (Kima, Italy)管中进行自动化检测,将3.8%柠檬酸钠(Na-citrate, Kima, Italy)管中进行Westergren检测。根据Westergren法获得的ESR值将数据分为三组:低组(L) (ESR≤20 mm)、中组(M) (ESR 21 ~ 60 mm)和高组(H) (ESR≥61 mm)。采用Bland-Altman分析和Passing-Bablok回归评价方法一致性。结果:在整个测量中,分析仪ed与Westergren方法(偏差0.0 (95%Cl -1.4至1.5)范围比Roller 20 PN(偏差= - 6.4 (95%Cl - 7.1至-5.7))具有更好的可比性。对于Roller 20 PN, Passing-Bablok回归在L组和M组中显示出不变的比例差异,而对于iSED仅在h组中显示出不变的比例差异。Roller 20 PN的敏感性(0.51 (95%Cl: 0.45-0.57)低于iSED (0.72 (95%Cl: 0.59-0.80)),而与Westergren方法相比,它们具有相当的特异性(> 0.90)和准确性(≥0.80)。结论:两种分析仪与Westergren法不具有可比性,不应互换使用。
{"title":"Verification of automatic analysers Roller 20PN and iSED for measuring erythrocyte sedimentation rate.","authors":"Helena Čičak,&nbsp;Pavica Šonjić,&nbsp;Ana-Maria Šimundić","doi":"10.11613/BM.2022.010708","DOIUrl":"https://doi.org/10.11613/BM.2022.010708","url":null,"abstract":"<p><strong>Introduction: </strong>Automated erythrocyte sedimentation rate (ESR) analysers are based on different methodology than Westergren method. It is questionable whether ESR values obtained from those analysers are comparable with determined values with Westergren method. The aim was verification of the precision, method comparison and accuracy of automated ESR analysers: Roller 20PN (Alifax S.p.A., Polverara, Italy) and iSED (Alcor Scientific, Smithfield, USA).</p><p><strong>Materials and methods: </strong>Blood samples (N = 752 for Roller 20PN and N = 213 for iSED) were sampled into K<sub>2</sub>EDTA (Kima, Italy) tubes for automated and 3.8% Na-citrate tubes (Kima, Italy) for Westergren method. The data was divided into three groups according to the ESR values obtained with the Westergren method: Group Low (L) (ESR ≤ 20 mm), Group Medium (M) (ESR 21-60 mm), and Group High (H) (ESR ≥ 61 mm). Method agreement was assessed by Bland-Altman analysis and Passing-Bablok regression.</p><p><strong>Results: </strong>Analyser iSED has shown better comparability with Westergren method (bias 0.0 (95%Cl -1.4 to 1.5) range than Roller 20 PN (bias = - 6.4 (95%Cl - 7.1 to -5.7) in the whole measuring. For Roller 20 PN, Passing-Bablok regression has shown constant and proportional difference for Groups L and M, and for iSED only for Group H. Roller 20 PN had lower sensitivity (0.51 (95%Cl: 0.45-0.57) than iSED (0.72 (95%Cl: 0.59-0.80) while they had comparable specificity (> 0.90) and accuracy (≥ 0.80) in comparison with the Westergren method.</p><p><strong>Conclusion: </strong>Both analysers are not comparable with the Westergren method and should not be used interchangeably.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"32 1","pages":"010708"},"PeriodicalIF":3.3,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39834173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Haemoglobin A1c-based screening for prediabetes and diabetes mellitus: a multi-center study in Croatian adult population. 基于血红蛋白1c筛查前驱糖尿病和糖尿病:克罗地亚成年人的多中心研究
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2022-02-15 Epub Date: 2021-12-15 DOI: 10.11613/BM.2022.010903
Ivana Lapić, Dunja Rogić, Nora Nikolac Gabaj, Katarina Kajić, Nena Peran, Lada Surjan, Anamarija Đuras, Valentina Cesar Kocijan, Nada Bilopavlović, Fran Smaić, Mario Štefanović, Ivanka Ostroški, Leida Tandara, Milena Krnjaić-Tadijanović, Ivan Gornik, Hrvoje Pintarić, Daniela Marasović Krstulović, Blaženka Miškić, Dario Rahelić

Introduction: Based on the hypothesis that there is a substantial rate of adults with prediabetes and undiagnosed diabetes mellitus (DM), our aim was to perform haemoglobin A1c (HbA1c)-based screening in a cohort of Croatian adults and estimate the prevalence of prediabetes and undiagnosed DM according to American Diabetes Association criteria.

Materials and methods: This multi-center, cross-sectional study performed in six Croatian hospitals included 5527 patients aged 40 to 70 years admitted to the Emergency Department or undergoing a primary care check-up. Haemoglobin A1c was measured from leftover whole blood samples using the enzymatic method on either Alinity c or Architect c-series analyser (Abbott Laboratories, Chicago, USA). Haemoglobin A1c between 39-47 mmol/mol was classified as prediabetes, while ≥ 48 mmol/mol as undiagnosed DM.

Results: After exclusion of 435 patients with known DM, the final cohort included 5092 patients (median age 57; 56% males). A total of 882 (17.3%) patients had HbA1c values between 39 and 47 mmol/mol. There were 214 (4.2%) patients with HbA1c ≥ 48 mmol/mol. Prediabetes prevalence ranged from 14.2% to 20.5%, while undiagnosed DM from 3.3% to 7.3%, with statistically significant differences among settings (P < 0.001). Age-stratified analysis showed that prediabetes and undiagnosed DM prevalence increase with age (P < 0.001), being 25.4% and 5.8%, respectively, in patients aged 60 to 70 years.

Conclusion: Underlying impairment of glucose metabolism was identified in about one in five adults, with significant number of patients with already overt DM. These results should serve as a starting point for further steps directed towards promotion of preventive measures for DM in Croatia.

引言:基于有相当比例的成年人患有前驱糖尿病和未确诊糖尿病(DM)的假设,我们的目的是在克罗地亚成年人队列中进行基于血红蛋白A1c (HbA1c)的筛查,并根据美国糖尿病协会的标准估计前驱糖尿病和未确诊糖尿病的患病率。材料和方法:这项多中心、横断面研究在克罗地亚6家医院进行,包括5527名年龄在40至70岁之间的患者,他们被急诊室收治或接受初级保健检查。用酶法在Alinity c或Architect c系列分析仪(Abbott Laboratories, Chicago, USA)上检测剩余全血样本的血红蛋白A1c。血红蛋白A1c在39-47 mmol/mol之间被归类为前驱糖尿病,而≥48 mmol/mol被归类为未确诊的DM。结果:在排除了435例已知DM患者后,最终队列包括5092例患者(中位年龄57;56%的男性)。共有882例(17.3%)患者的HbA1c值在39 - 47 mmol/mol之间。HbA1c≥48 mmol/mol的患者214例(4.2%)。糖尿病前期患病率为14.2% ~ 20.5%,未确诊糖尿病患病率为3.3% ~ 7.3%,各设置间差异有统计学意义(P < 0.001)。年龄分层分析显示,糖尿病前期和未确诊的糖尿病患病率随年龄增加(P < 0.001),在60 ~ 70岁的患者中分别为25.4%和5.8%。结论:在大约五分之一的成年人中发现了潜在的糖代谢障碍,其中有相当数量的患者已经患有显性糖尿病。这些结果应该作为克罗地亚进一步促进糖尿病预防措施的起点。
{"title":"Haemoglobin A1c-based screening for prediabetes and diabetes mellitus: a multi-center study in Croatian adult population.","authors":"Ivana Lapić,&nbsp;Dunja Rogić,&nbsp;Nora Nikolac Gabaj,&nbsp;Katarina Kajić,&nbsp;Nena Peran,&nbsp;Lada Surjan,&nbsp;Anamarija Đuras,&nbsp;Valentina Cesar Kocijan,&nbsp;Nada Bilopavlović,&nbsp;Fran Smaić,&nbsp;Mario Štefanović,&nbsp;Ivanka Ostroški,&nbsp;Leida Tandara,&nbsp;Milena Krnjaić-Tadijanović,&nbsp;Ivan Gornik,&nbsp;Hrvoje Pintarić,&nbsp;Daniela Marasović Krstulović,&nbsp;Blaženka Miškić,&nbsp;Dario Rahelić","doi":"10.11613/BM.2022.010903","DOIUrl":"https://doi.org/10.11613/BM.2022.010903","url":null,"abstract":"<p><strong>Introduction: </strong>Based on the hypothesis that there is a substantial rate of adults with prediabetes and undiagnosed diabetes mellitus (DM), our aim was to perform haemoglobin A1c (HbA<sub>1c</sub>)-based screening in a cohort of Croatian adults and estimate the prevalence of prediabetes and undiagnosed DM according to American Diabetes Association criteria.</p><p><strong>Materials and methods: </strong>This multi-center, cross-sectional study performed in six Croatian hospitals included 5527 patients aged 40 to 70 years admitted to the Emergency Department or undergoing a primary care check-up. Haemoglobin A1c was measured from leftover whole blood samples using the enzymatic method on either Alinity c or Architect c-series analyser (Abbott Laboratories, Chicago, USA). Haemoglobin A1c between 39-47 mmol/mol was classified as prediabetes, while ≥ 48 mmol/mol as undiagnosed DM.</p><p><strong>Results: </strong>After exclusion of 435 patients with known DM, the final cohort included 5092 patients (median age 57; 56% males). A total of 882 (17.3%) patients had HbA<sub>1c</sub> values between 39 and 47 mmol/mol. There were 214 (4.2%) patients with HbA<sub>1c</sub> ≥ 48 mmol/mol. Prediabetes prevalence ranged from 14.2% to 20.5%, while undiagnosed DM from 3.3% to 7.3%, with statistically significant differences among settings (P < 0.001). Age-stratified analysis showed that prediabetes and undiagnosed DM prevalence increase with age (P < 0.001), being 25.4% and 5.8%, respectively, in patients aged 60 to 70 years.</p><p><strong>Conclusion: </strong>Underlying impairment of glucose metabolism was identified in about one in five adults, with significant number of patients with already overt DM. These results should serve as a starting point for further steps directed towards promotion of preventive measures for DM in Croatia.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"32 1","pages":"010903"},"PeriodicalIF":3.3,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672385/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39851750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The concurrence of the current postanalytical phase management with the national recommendations: a survey of the Working Group for Postanalytics of the Croatian Society of Medical Biochemistry and Laboratory Medicine. 目前的分析后阶段管理与国家建议的一致性:克罗地亚医学生物化学和实验室医学学会后分析工作组的调查。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-10-15 DOI: 10.11613/BM.2021.030704
Anja Jokic, Vladimira Rimac, Jelena Vlasic Tanaskovic, Sonja Podolar, Lorena Honovic, Jasna Lenicek Krleza

Introduction: The detection and prevention of errors in the postanalytical phase can be done through the harmonization and standardization of constituent parts of this phase of laboratory work. The aim was to investigate how well the ongoing management of the postanalytical phase corresponds to the document "Post-analytical laboratory work: national recommendations" in Croatian medical biochemistry laboratories (MBLs).

Materials and methods: All 195 MBLs participating in the national external quality assessment scheme, were invited to undertake a part in a survey. Through 23 questions the participants were asked about management of the reference intervals (RI), delta check, reflex/reflective testing, postanalytical quality indicators and other parts of the postanalytical phase recommended in the national recommendations. The results are presented in numbers and percentages.

Results: Out of 195 MBLs, 119 participated in the survey, giving a response rate of 61%. Not all of the respondents provided answers to all the questions. Delta check has not been used in 59% (70/118) of the laboratories. Only 22/113 (20%) laboratories use reflex and/or reflective testing. In 53% of the laboratories, critical results were reported within 30 minutes of the confirmation of the results. In 34% (40/118) of the laboratories, turnaround time and reporting of critical results are two most often monitored postanalytical quality indicators.

Conclusion: The results showed the critical results reporting and monitoring of postanalytical quality indicators are in the line with the recommendations. However, the management of RI verification, the use of delta check and reflex/reflective testing still must be harmonized among Croatian MBLs.

介绍:分析后阶段的错误检测和预防可以通过协调和标准化这一阶段实验室工作的组成部分来完成。目的是调查克罗地亚医学生物化学实验室目前对分析后阶段的管理是否符合文件"分析后实验室工作:国家建议"。材料与方法:对参加国家外部质量评价计划的195家mbl进行问卷调查。通过23个问题,参与者被问及参考区间(RI)的管理、delta检查、反射/反射测试、分析后质量指标和国家建议中建议的分析后阶段的其他部分。结果以数字和百分比表示。结果:195个mbl中有119个参与了调查,回复率为61%。并非所有受访者都回答了所有问题。59%(70/118)的实验室未使用Delta检查。只有22/113(20%)的实验室使用反射和/或反射检测。在53%的实验室中,关键结果在结果确认后30分钟内报告。在34%(40/118)的实验室中,周转时间和关键结果报告是两个最常监测的分析后质量指标。结论:分析后质量指标的关键结果报告和监测符合建议。但是,克罗地亚的MBLs之间仍然必须协调RI核查的管理、delta检查和反射/反射测试的使用。
{"title":"The concurrence of the current postanalytical phase management with the national recommendations: a survey of the Working Group for Postanalytics of the Croatian Society of Medical Biochemistry and Laboratory Medicine.","authors":"Anja Jokic,&nbsp;Vladimira Rimac,&nbsp;Jelena Vlasic Tanaskovic,&nbsp;Sonja Podolar,&nbsp;Lorena Honovic,&nbsp;Jasna Lenicek Krleza","doi":"10.11613/BM.2021.030704","DOIUrl":"https://doi.org/10.11613/BM.2021.030704","url":null,"abstract":"<p><strong>Introduction: </strong>The detection and prevention of errors in the postanalytical phase can be done through the harmonization and standardization of constituent parts of this phase of laboratory work. The aim was to investigate how well the ongoing management of the postanalytical phase corresponds to the document \"Post-analytical laboratory work: national recommendations\" in Croatian medical biochemistry laboratories (MBLs).</p><p><strong>Materials and methods: </strong>All 195 MBLs participating in the national external quality assessment scheme, were invited to undertake a part in a survey. Through 23 questions the participants were asked about management of the reference intervals (RI), delta check, reflex/reflective testing, postanalytical quality indicators and other parts of the postanalytical phase recommended in the national recommendations. The results are presented in numbers and percentages.</p><p><strong>Results: </strong>Out of 195 MBLs, 119 participated in the survey, giving a response rate of 61%. Not all of the respondents provided answers to all the questions. Delta check has not been used in 59% (70/118) of the laboratories. Only 22/113 (20%) laboratories use reflex and/or reflective testing. In 53% of the laboratories, critical results were reported within 30 minutes of the confirmation of the results. In 34% (40/118) of the laboratories, turnaround time and reporting of critical results are two most often monitored postanalytical quality indicators.</p><p><strong>Conclusion: </strong>The results showed the critical results reporting and monitoring of postanalytical quality indicators are in the line with the recommendations. However, the management of RI verification, the use of delta check and reflex/reflective testing still must be harmonized among Croatian MBLs.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030704"},"PeriodicalIF":3.3,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495617/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39527906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Establishing paediatric reference intervals for thyroid function tests in Croatian population on the Abbott Architect i2000. 根据雅培建筑师i2000,在克罗地亚人口中建立甲状腺功能测试的儿科参考间隔。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-10-15 Epub Date: 2021-08-05 DOI: 10.11613/BM.2021.030702
Adriana Bokulić, Ivana Zec, Domagoj Marijančević, Sanja Goreta, Marija Požgaj Šepec, Lavinia La Grasta Sabolić

Introduction: Evaluation of thyroid function is often requested and therefore defining paediatric reference intervals (RIs) is of vital importance. Currently, there is a distinct lack of paediatric RIs for thyroid function tests in Croatia. Thus, we established RIs for thyroid stimulating hormone (TSH), total triiodothyronine (TT3), total thyroxine (TT4), free triiodothyronine (FT3) and free thyroxine (FT4) in the Croatian paediatric population.

Materials and methods: Reference intervals were calculated from 397 apparently healthy children, aged from 2 days to < 19 years. Serum samples were analysed for thyroid function tests on the Abbott Architect i2000. Age- and sex-specific 95% RIs with 90% confidence intervals were established according to Clinical and Laboratory Standards Institute guidelines. To express the magnitude of sex and age variation, standard deviation ratio (SDR) was calculated using two-level nested ANOVA. The criterion for considering partitioning reference values was set to SDR > 0.3.

Results: All thyroid function tests required age partitioning, confirmed by SDR above 0.3. There was no need for sex partitioning, confirmed by SDR below 0.3. Still, FT3 was partitioned due to visually noticeable sex related difference for the oldest group (12 years to < 19 years).

Conclusion: This is the first study to establish RIs for thyroid function tests in the Croatian paediatric population. We propose RIs for widely used Abbott platform, thus giving laboratories method- and population-specific paediatric RIs for thyroid function tests that should improve clinical test interpretation.

简介:甲状腺功能评估经常被要求,因此确定儿科参考区间(RIs)是至关重要的。目前,克罗地亚明显缺乏用于甲状腺功能检测的儿科RIs。因此,我们在克罗地亚儿科人群中建立了促甲状腺激素(TSH)、总三碘甲状腺原氨酸(TT3)、总甲状腺素(TT4)、游离三碘甲状腺原氨酸(FT3)和游离甲状腺素(FT4)的RIs。材料与方法:选取397例2天~ < 19岁的明显健康儿童,计算参考区间。在雅培Architect i2000上分析血清样本进行甲状腺功能测试。根据临床和实验室标准协会的指导方针,确定了年龄和性别特异性95%的RIs和90%的置信区间。为了表达性别和年龄变化的程度,采用双水平嵌套方差分析计算标准差比(SDR)。考虑分区参考值的标准设为SDR > 0.3。结果:所有甲状腺功能检查均需要年龄划分,SDR均在0.3以上。不需要性别划分,SDR在0.3以下证实。然而,由于年龄最大的组(12岁至< 19岁)在视觉上存在明显的性别相关差异,FT3被划分。结论:这是首个在克罗地亚儿科人群中建立甲状腺功能检测RIs的研究。我们建议广泛使用雅培平台的RIs,从而为实验室提供方法和人群特异性的儿科甲状腺功能检测RIs,这应该改善临床测试的解释。
{"title":"Establishing paediatric reference intervals for thyroid function tests in Croatian population on the Abbott Architect i2000.","authors":"Adriana Bokulić,&nbsp;Ivana Zec,&nbsp;Domagoj Marijančević,&nbsp;Sanja Goreta,&nbsp;Marija Požgaj Šepec,&nbsp;Lavinia La Grasta Sabolić","doi":"10.11613/BM.2021.030702","DOIUrl":"https://doi.org/10.11613/BM.2021.030702","url":null,"abstract":"<p><strong>Introduction: </strong>Evaluation of thyroid function is often requested and therefore defining paediatric reference intervals (RIs) is of vital importance. Currently, there is a distinct lack of paediatric RIs for thyroid function tests in Croatia. Thus, we established RIs for thyroid stimulating hormone (TSH), total triiodothyronine (TT3), total thyroxine (TT4), free triiodothyronine (FT3) and free thyroxine (FT4) in the Croatian paediatric population.</p><p><strong>Materials and methods: </strong>Reference intervals were calculated from 397 apparently healthy children, aged from 2 days to < 19 years. Serum samples were analysed for thyroid function tests on the Abbott Architect i2000. Age- and sex-specific 95% RIs with 90% confidence intervals were established according to Clinical and Laboratory Standards Institute guidelines. To express the magnitude of sex and age variation, standard deviation ratio (SDR) was calculated using two-level nested ANOVA. The criterion for considering partitioning reference values was set to SDR > 0.3.</p><p><strong>Results: </strong>All thyroid function tests required age partitioning, confirmed by SDR above 0.3. There was no need for sex partitioning, confirmed by SDR below 0.3. Still, FT3 was partitioned due to visually noticeable sex related difference for the oldest group (12 years to < 19 years).</p><p><strong>Conclusion: </strong>This is the first study to establish RIs for thyroid function tests in the Croatian paediatric population. We propose RIs for widely used Abbott platform, thus giving laboratories method- and population-specific paediatric RIs for thyroid function tests that should improve clinical test interpretation.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030702"},"PeriodicalIF":3.3,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39311867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients. 克罗地亚实体器官移植受者中SARS-CoV-2的血清阳性率
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-10-15 DOI: 10.11613/BM.2021.030901
Anna Mrzljak, Željka Jureković, Jadranka Pavičić-Šarić, Vladimir Stevanović, Irena Tabain, Željka Hruškar, Danko Mikulić, Ljubo Barbić, Tatjana Vilibić-Čavlek

Introduction: The data on the coronavirus disease (COVID-19) in solid-organ transplant recipients (SOTRs) in Croatia is unknown. The aim of this study was to analyze the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Croatian SOTRs.

Materials and methods: From 7 September to 27 November 2020 (beginning of the second COVID-19 pandemic wave), a cross-sectional screening for COVID-19 was performed in the adult outpatient liver (LTRs; N = 280) and kidney transplant recipients (KTRs; N = 232). Serum samples were initially tested for SARS-CoV-2 IgG antibodies using a commercial enzyme-linked immunosorbent assay (ELISA; Vircell Microbiologists, Granada, Spain). All positive samples were confirmed using a virus neutralization test (VNT). Data on risk exposure and COVID-19 related symptoms were collected using a questionnaire.

Results: The transplanted cohort's seroprevalence detected by ELISA and VNT was 20.1% and 3.1%, respectively. Neutralizing (NT) antibodies developed in 15.6% of anti-SARS-CoV-2 ELISA IgG positive SOTRs. The difference in seropositivity rates between LTRs and KTRs was not statistically significant (ELISA 21.1% vs. 19.0%, P = 0.554; VNT 3.6% vs. 2.6%, P = 0.082). Overall VNT positivity rates were higher in patients who reported participation in large community events (5.9% vs. 1.0%; P = 0.027) as well as in patients who reported COVID-19 related symptoms in the past six months. In addition, symptomatic VNT positive patients showed significantly higher (P = 0.031) NT antibody titers (median 128, interquartile range (IQR) = 32-128) compared to asymptomatic patients (median 16, IQR = 16-48).

Conclusions: This study showed that 15.6% of anti-SARS-CoV-2 ELISA positive Croatian SOTRs developed NT antibodies indicating protective immunity. Further studies are needed to determine the dynamic of NT antibodies and COVID-19 immunity duration in immunocompromised populations such as LTRs and KTRs.

克罗地亚实体器官移植受者(SOTRs)中冠状病毒病(COVID-19)的数据尚不清楚。本研究的目的是分析克罗地亚sotr中严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)的血清患病率。材料和方法:2020年9月7日至11月27日(第二波COVID-19大流行开始),对成人门诊肝脏(lts)进行COVID-19横断面筛查;N = 280)和肾移植受者(KTRs;N = 232)。使用商用酶联免疫吸附试验(ELISA)对血清样本进行SARS-CoV-2 IgG抗体的初步检测;Vircell微生物学家,格拉纳达,西班牙)。所有阳性样本均采用病毒中和试验(VNT)进行确认。使用问卷收集风险暴露和COVID-19相关症状的数据。结果:ELISA和VNT检测移植队列血清阳性率分别为20.1%和3.1%。在15.6%的抗sars - cov -2 ELISA IgG阳性sotr中产生中和抗体。LTRs与KTRs血清阳性率差异无统计学意义(ELISA 21.1% vs. 19.0%, P = 0.554;VNT 3.6% vs. 2.6%, P = 0.082)。报告参加大型社区活动的患者VNT总体阳性率较高(5.9% vs 1.0%;P = 0.027),以及在过去6个月内报告有COVID-19相关症状的患者。此外,有症状的VNT阳性患者的NT抗体滴度(中位数128,四分位间距(IQR) = 32-128)明显高于无症状患者(中位数16,IQR = 16-48) (P = 0.031)。结论:本研究显示,15.6%的抗sars - cov -2 ELISA阳性的克罗地亚SOTRs产生NT抗体,表明具有保护性免疫。在ltr和ktr等免疫功能低下人群中,NT抗体动态和COVID-19免疫持续时间有待进一步研究。
{"title":"Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.","authors":"Anna Mrzljak,&nbsp;Željka Jureković,&nbsp;Jadranka Pavičić-Šarić,&nbsp;Vladimir Stevanović,&nbsp;Irena Tabain,&nbsp;Željka Hruškar,&nbsp;Danko Mikulić,&nbsp;Ljubo Barbić,&nbsp;Tatjana Vilibić-Čavlek","doi":"10.11613/BM.2021.030901","DOIUrl":"https://doi.org/10.11613/BM.2021.030901","url":null,"abstract":"<p><strong>Introduction: </strong>The data on the coronavirus disease (COVID-19) in solid-organ transplant recipients (SOTRs) in Croatia is unknown. The aim of this study was to analyze the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Croatian SOTRs.</p><p><strong>Materials and methods: </strong>From 7 September to 27 November 2020 (beginning of the second COVID-19 pandemic wave), a cross-sectional screening for COVID-19 was performed in the adult outpatient liver (LTRs; N = 280) and kidney transplant recipients (KTRs; N = 232). Serum samples were initially tested for SARS-CoV-2 IgG antibodies using a commercial enzyme-linked immunosorbent assay (ELISA; Vircell Microbiologists, Granada, Spain). All positive samples were confirmed using a virus neutralization test (VNT). Data on risk exposure and COVID-19 related symptoms were collected using a questionnaire.</p><p><strong>Results: </strong>The transplanted cohort's seroprevalence detected by ELISA and VNT was 20.1% and 3.1%, respectively. Neutralizing (NT) antibodies developed in 15.6% of anti-SARS-CoV-2 ELISA IgG positive SOTRs. The difference in seropositivity rates between LTRs and KTRs was not statistically significant (ELISA 21.1% <i>vs</i>. 19.0%, P = 0.554; VNT 3.6% <i>vs</i>. 2.6%, P = 0.082). Overall VNT positivity rates were higher in patients who reported participation in large community events (5.9% <i>vs</i>. 1.0%; P = 0.027) as well as in patients who reported COVID-19 related symptoms in the past six months. In addition, symptomatic VNT positive patients showed significantly higher (P = 0.031) NT antibody titers (median 128, interquartile range (IQR) = 32-128) compared to asymptomatic patients (median 16, IQR = 16-48).</p><p><strong>Conclusions: </strong>This study showed that 15.6% of anti-SARS-CoV-2 ELISA positive Croatian SOTRs developed NT antibodies indicating protective immunity. Further studies are needed to determine the dynamic of NT antibodies and COVID-19 immunity duration in immunocompromised populations such as LTRs and KTRs.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030901"},"PeriodicalIF":3.3,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495621/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39527910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Your article needs revision? - How to improve it successfully and answer to the reviewers' comments. 你的文章需要修改吗?-如何成功地改进并回应审稿人的意见。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-10-15 DOI: 10.11613/BM.2021.030301
Daria Pašalić, Adrijana Dorotić, Patricija Banković-Radovanović
©Copyright by Croatian Society of Medical Biochemistry and Laboratory Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon the material, provided the original work is properly cited and any changes properly indicated . Introduction
{"title":"Your article needs revision? - How to improve it successfully and answer to the reviewers' comments.","authors":"Daria Pašalić,&nbsp;Adrijana Dorotić,&nbsp;Patricija Banković-Radovanović","doi":"10.11613/BM.2021.030301","DOIUrl":"https://doi.org/10.11613/BM.2021.030301","url":null,"abstract":"©Copyright by Croatian Society of Medical Biochemistry and Laboratory Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon the material, provided the original work is properly cited and any changes properly indicated . Introduction","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030301"},"PeriodicalIF":3.3,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495623/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39550505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wilfully submitting to and publishing in predatory journals - a covert form of research misconduct? 故意向掠夺性期刊投稿并在其上发表文章--一种隐蔽的研究不当行为?
IF 3.8 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-10-15 Epub Date: 2021-08-05 DOI: 10.11613/BM.2021.030201
Nicole Shu Ling Yeo-Teh, Bor Luen Tang

A predatory journal could be provisionally defined as one masquerading as a genuine academic publication but offer little, if any, rigorous peer review. Predatory journals or publishers place a focus on maximising financial profit, as opposed to regulated dissemination of scientific advancements. As a result, authors can often get their work published in such journals with little scrutiny on quality. Although generally warned against and discouraged, universally practiced sanctions against researchers' submission to and publication in predatory journals are not common. Predatory publishing thus remains prevalent, particularly in places where academic success is measured by the quantity rather than quality of publication output, which feeds the journal's business model that thrives upon significant market demand. However, such an undesirable enterprise has the potential to flood the scientific literature with unsound research that could be misleadingly perceived as authoritative. This may result in or add to the confusion of policy makers and the layperson, consequentially bringing disrepute to science and all parties involved. Here, we argue that wilfully submitting one's manuscript to a predatory journal may constitute an active act of avoidance of rigorous peer review of one's work. If such is the intention, it would be a questionable research practice and could be considered an, albeit covert, form of scientific misconduct. If labelled as such, and with institutional and funding rules erected to discourage the practice, predatory publishing could be effectively put out of business through diminishing the consumer demand.

掠夺性期刊可暂时定义为伪装成真正的学术出版物,但几乎不提供任何严格的同行评审的期刊。掠夺性期刊或出版商注重经济利益最大化,而不是规范地传播科学进步。因此,作者往往可以在这类期刊上发表自己的作品,而几乎不需要对质量进行审查。尽管一般都会警告和阻止研究人员向掠夺性期刊投稿和发表论文,但普遍实行的制裁措施并不常见。因此,掠夺性出版依然盛行,尤其是在那些以出版物数量而非质量来衡量学术成就的地方,这为期刊的商业模式提供了巨大的市场需求。然而,这种不可取的做法有可能使科学文献中充斥着不靠谱的研究,让人误以为这些研究具有权威性。这可能会导致或加剧决策者和非专业人士的困惑,从而使科学和所有相关方蒙羞。在此,我们认为,故意向掠夺性期刊投稿可能构成一种主动回避对其工作进行严格同行评审的行为。如果意图如此,这将是一种值得商榷的研究行为,可被视为一种隐蔽的科学不端行为。如果被贴上这样的标签,并制定机构和资助规则来阻止这种做法,那么掠夺性出版就可以通过减少消费者的需求而被有效地淘汰。
{"title":"Wilfully submitting to and publishing in predatory journals - a covert form of research misconduct?","authors":"Nicole Shu Ling Yeo-Teh, Bor Luen Tang","doi":"10.11613/BM.2021.030201","DOIUrl":"10.11613/BM.2021.030201","url":null,"abstract":"<p><p>A predatory journal could be provisionally defined as one masquerading as a genuine academic publication but offer little, if any, rigorous peer review. Predatory journals or publishers place a focus on maximising financial profit, as opposed to regulated dissemination of scientific advancements. As a result, authors can often get their work published in such journals with little scrutiny on quality. Although generally warned against and discouraged, universally practiced sanctions against researchers' submission to and publication in predatory journals are not common. Predatory publishing thus remains prevalent, particularly in places where academic success is measured by the quantity rather than quality of publication output, which feeds the journal's business model that thrives upon significant market demand. However, such an undesirable enterprise has the potential to flood the scientific literature with unsound research that could be misleadingly perceived as authoritative. This may result in or add to the confusion of policy makers and the layperson, consequentially bringing disrepute to science and all parties involved. Here, we argue that wilfully submitting one's manuscript to a predatory journal may constitute an active act of avoidance of rigorous peer review of one's work. If such is the intention, it would be a questionable research practice and could be considered an, albeit covert, form of scientific misconduct. If labelled as such, and with institutional and funding rules erected to discourage the practice, predatory publishing could be effectively put out of business through diminishing the consumer demand.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030201"},"PeriodicalIF":3.8,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39311865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of specimen haemolysis on complete blood count results by Abbott Alinity hq System. 标本溶血对Abbott Alinity hq系统全血细胞计数结果的影响。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-10-15 DOI: 10.11613/BM.2021.030706
Müjgan Ercan, Emiş Deniz Akbulut, Nihayet Bayraktar, Şerif Ercan

Introduction: The current study aimed to assess the interference of in vitro haemolysis on complete blood count (CBC) using Abbott Alinity hq system, and to determine which haemolysis levels affect the reliability of sample results.

Materials and methods: Blood samples obtained from 25 volunteers in K3-EDTA tubes were divided into four aliquots. The first aliquot was not subjected to any intervention. The second, third and fourth aliquots were passed through a fine needle 2, 4 and 6 times, respectively. Complete blood count was performed by multi-angle polarized scatter separation technology and haemolysis index (HI) was assessed from the plasma samples separated by centrifugation. Five groups were formed according to the HI values. The percentage biases between the results of non-haemolysed and haemolysed groups were compared with the desirable bias limits from The European Federation of Clinical Chemistry and Laboratory Medicine database and reference change values (RCVs).

Results: In groups 1 to 4, the effects of haemolysis on CBC parameters were acceptable comparing to the analytical bias except for lymphocytes (7.26%-7.42%), MCH (2.59%), and MCHC (0.47%-2.81%). Results of group 5 (gross haemolysis) showed decreases in HCT(- 4.56%), RBC (- 4.07%) count and increase in lymphocyte (11.60%) count higher than the analytical performance specifications. Moreover, variations in MCH (4.65%) and MCHC (5.24%) were exceeding the RCVs.

Conclusions: Gross haemolysis (haemoglobin concentration > 10 g/L) is likely to produce unreliable CBC results on non-pathological samples. Further studies including pathological specimens are needed.

本研究旨在评估体外溶血对雅培Alinity hq系统全血细胞计数(CBC)的干扰,并确定哪些溶血水平会影响样品结果的可靠性。材料与方法:25名志愿者经K3-EDTA管采血,分为4份。第一组没有受到任何干预。第二个、第三个和第四个等分分别穿过细针2次、4次和6次。采用多角度极化散射分离技术测定全血细胞计数,离心分离血浆样品测定溶血指数(HI)。根据HI值分为五组。将非溶血组和溶血组结果之间的百分比偏差与欧洲临床化学和实验室医学联合会数据库和参考变化值(rcv)的理想偏差限值进行比较。结果:在1 ~ 4组中,除淋巴细胞(7.26% ~ 7.42%)、MCH(2.59%)和MCHC(0.47% ~ 2.81%)外,溶血对CBC参数的影响与分析偏差相比是可以接受的。结果5组(总溶血)HCT(- 4.56%)、RBC(- 4.07%)计数下降,淋巴细胞计数增加(11.60%),高于分析性能标准。此外,MCH(4.65%)和MCHC(5.24%)的变化均超过rcv。结论:肉眼溶血(血红蛋白浓度> 10 g/L)可能对非病理样本产生不可靠的CBC结果。需要进一步的研究,包括病理标本。
{"title":"Effects of specimen haemolysis on complete blood count results by Abbott Alinity hq System.","authors":"Müjgan Ercan,&nbsp;Emiş Deniz Akbulut,&nbsp;Nihayet Bayraktar,&nbsp;Şerif Ercan","doi":"10.11613/BM.2021.030706","DOIUrl":"https://doi.org/10.11613/BM.2021.030706","url":null,"abstract":"<p><strong>Introduction: </strong>The current study aimed to assess the interference of <i>in vitro</i> haemolysis on complete blood count (CBC) using Abbott Alinity hq system, and to determine which haemolysis levels affect the reliability of sample results.</p><p><strong>Materials and methods: </strong>Blood samples obtained from 25 volunteers in K3-EDTA tubes were divided into four aliquots. The first aliquot was not subjected to any intervention. The second, third and fourth aliquots were passed through a fine needle 2, 4 and 6 times, respectively. Complete blood count was performed by multi-angle polarized scatter separation technology and haemolysis index (HI) was assessed from the plasma samples separated by centrifugation. Five groups were formed according to the HI values. The percentage biases between the results of non-haemolysed and haemolysed groups were compared with the desirable bias limits from The European Federation of Clinical Chemistry and Laboratory Medicine database and reference change values (RCVs).</p><p><strong>Results: </strong>In groups 1 to 4, the effects of haemolysis on CBC parameters were acceptable comparing to the analytical bias except for lymphocytes (7.26%-7.42%), MCH (2.59%), and MCHC (0.47%-2.81%). Results of group 5 (gross haemolysis) showed decreases in HCT(- 4.56%), RBC (- 4.07%) count and increase in lymphocyte (11.60%) count higher than the analytical performance specifications. Moreover, variations in MCH (4.65%) and MCHC (5.24%) were exceeding the RCVs.</p><p><strong>Conclusions: </strong>Gross haemolysis (haemoglobin concentration > 10 g/L) is likely to produce unreliable CBC results on non-pathological samples. Further studies including pathological specimens are needed.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030706"},"PeriodicalIF":3.3,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39527908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Biochemia Medica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1